Filing Details
- Accession Number:
- 0001104659-20-026412
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-27 19:49:35
- Reporting Period:
- 2020-02-24
- Accepted Time:
- 2020-02-27 19:49:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636050 | Axovant Gene Therapies Ltd. | AXGT | () | D0 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635088 | Ltd. Sciences Roivant | Suite 1, 3Rd Floor 11-12 St. James'S Square London X0 SW1Y 4LB | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, Par Value $0.00001 Per Share | Acquisiton | 2020-02-24 | 5,333,333 | $3.75 | 18,577,380 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
